Arcus Development Group Stock
Your prediction
Pros and Cons of Arcus Development Group in the next few years
Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Arcus Development Group vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Arcus Development Group | - | - | - | - | - | - | - |
| Bravada Gold Corp. | 109.090% | -13.158% | 26.923% | 3.125% | 106.250% | -34.000% | -81.667% |
| Monument Mining Ltd | 11.890% | 16.667% | 25.781% | 325.926% | 314.948% | 1763.426% | 1337.500% |
| Blue Star Gold Corp. | 5.260% | 17.526% | 39.024% | 936.364% | 936.364% | -25.000% | -72.195% |
News
Arcus Biosciences President Sells $2 Million in Stock Under Trading Plan
Juan C. Jaen, the president of Arcus Biosciences (NYSE:RCUS), sold 96,859 shares in multiple open-market transactions on Tuesday and Wednesday, according to an SEC Form 4 filing.
The transaction
Arcus (RCUS) Q2 Revenue Jumps 310%
Arcus Biosciences (NYSE:RCUS), a clinical-stage biotech focused on cancer immunotherapies, reported its second-quarter 2025 earnings on August 6, 2025. GAAP revenue and earnings per share both